4Dwight T, Nelso AE, Marsh DJ, et al. Parathyroid tumorigenesis in association with primary hyperparathyroidism. Curr Opin Endocrinol Diabetes, 2002,9:51-60.
5Toni R. Prezant, Melmed S. Molecular pathogenesis of pituitary disorders. Curr Opin Endocrinol Diabetes, 2002,9:61-78.
6Sizemore GW. Multiple endocrine neoplasia. In Backer K (ed), Principles and practice of Endocrinology and Metabolism, 3rd ed. Philadelphia Baltimore: Lippincotts Wilkins & Williams, 2001.1696-1706.
2Nicole E, Dietrich K, Wolfang H, et al. Typical ocular findings in a patient with multiple endocrine neoplasia type 2b syndrome. Graefe′s Arch Clin Exp Ophthalmol, 2001,239:391-394.
3Heshmati HM, Hofbauer LC. Multiple endocridrone neoplasia type 2: recent progression in diagnosis and management. Eur J Endocrinol, 1997,137:572-578.
4Hamet P, Pausova Z, Adarichev V, et al. Hypertension: genes and environment. J Hypertens, 1998,16:397-418.
5Mulligan LM, Marsh DJ, Robinson BG, et al. Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium. J Intern Med, 1995,238:343-346.
6Sipple JH. The association of pheochromocytoma with carcinoma of the thyroid gland. Am J Med, 1961,31:163-166.
7Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mtation consortium analysis. JAMA, 1996,276:1575-1579.
9Eng C. RET proto-oncogene in the development of human cancer. J Clin Oncol, 1999,17:380-393.
10Mulligan LM, Kwok JBJ, Healey CS, et al. Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type Ⅱa. Nature, 1993,363:458-460.
